Thursday, March 07, 2024 6:18:37 AM
"Especially when that treatment is applied under the false premise of an histologically unfounded statement about my imminent demise by the clinical trial patient procurement nurse." Hmmm...I thought it was a he that called you and suggested that you might not have long to live.
"Further, before I sacked the Oncologist, he did arrange for the Hospice to attend my home to initiate immediate end of life palliative care, when I told him there had been a mistake." How can you sack someone that you did not hire...i.e. you sad you never gave informed consent?
"There is also a massive amount of evidence the NICE & MHRA have," about what? Your situation?
"That is a wholly rational position for a former patient to take, as opposed to yours,?which is purely driven by greed as a shareholder." Shareholder, yes, however am interested also in ridding the world of cancer, and I believe that DCVAX-L and DIRECT in combination with immuno therapies will do that.
BTW, I thought you were leaving this site about 10 posts ago?
"Further, before I sacked the Oncologist, he did arrange for the Hospice to attend my home to initiate immediate end of life palliative care, when I told him there had been a mistake." How can you sack someone that you did not hire...i.e. you sad you never gave informed consent?
"There is also a massive amount of evidence the NICE & MHRA have," about what? Your situation?
"That is a wholly rational position for a former patient to take, as opposed to yours,?which is purely driven by greed as a shareholder." Shareholder, yes, however am interested also in ridding the world of cancer, and I believe that DCVAX-L and DIRECT in combination with immuno therapies will do that.
BTW, I thought you were leaving this site about 10 posts ago?
I am an Investment Advisor and run my own Investment Advisory Firm. Any comments are my own and are not to be used as investment advice. I own shares in NWBO
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
